A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery

FEMS Immunology and Medical Microbiology

Volumn 25, Issue 3, 1999, Pages 289-298

  Cano, François ^a   Liljeqvist, Sissela ^b   Nguyen, Thien N ^a   Samuelson, Patrik ^b   Bonnefoy, Jean Yves ^a   Ståhl, Stefan ^b   Robert, Alain ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Cholera toxin B subunit; Staphylococcus carnosus; Streptococcal protein G; Surface display; Vaccine delivery

Indexed keywords

CHIMERIC PROTEIN; CHOLERA TOXIN B SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; SECRETORY IMMUNOGLOBULIN; STAPHYLOCOCCUS VACCINE;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS CARNOSUS; THERMAL EXPOSURE; ULTRAVIOLET IRRADIATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CHOLERA TOXIN; DRUG CARRIERS; FEMALE; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NASAL MUCOSA; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCUS; STREPTOCOCCUS; VACCINES, SYNTHETIC;

EID: 0032809376     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00099-1     Document Type: Article

References (32)

1. Fischetti V.A., Medaglini D., Pozzi G. Gram-positive commensal bacteria for mucosal vaccine delivery. Curr. Opin. Biotechnol. 7:1996;659-666.
2. Georgiou G., Strathopoulos C., Daugherty P.S., Nayak A.R., Iverson B.L., Curtiss R.I. Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nature Biotechnol. 15:1997;29-34.
3. Ståhl S., Uhlén M. Bacterial surface display: trends and progress. Trends Biotechnol. 15:1997;185-192.
4. Hansson M., Ståhl S., Nguyen T.N., Bächi T., Robert A., Binz H., Sjölander A., Uhlén M. Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus. J. Bacteriol. 174:1992;4239-4245.
5. Samuelson P., Hansson M., Ahlborg N., Andréoni C., Götz F., Bächi T., Nguyen T.N., Binz H., Uhlén M., Ståhl S. Cell surface display of recombinant proteins on Staphylococcus carnosus. J. Bacteriol. 177:1995;1470-1476.
6. Nguyen T.N., Hansson M., Ståhl S., Bächi T., Robert A., Domzig W., Binz H., Uhlén M. Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination. Gene. 128:1993;89-94.
7. Nguyen T.N., Gourdon M.-H., Hansson M., Robert A., Samuelson P., Libon C., Andréoni C., Nygren P.-Å., Binz H., Uhlén M., Ståhl S. Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus. J. Biotechnol. 42:1995;207-219.
8. Robert A., Samuelson P., Andréoni C., Bächi T., Uhlén M., Binz H., Nguyen T.N., Ståhl S. Surface display on staphylococci: a comparative study. FEBS Lett. 390:1996;327-333.
9. Ståhl, S., Samuelson, P., Hansson, M., Andréoni, C., Goetsch, L., Libon, C., Liljeqvist, S., Gunneriusson, E., Binz, H., Nguyen, T.N. and Uhlén, M. (1997) Development of non-pathogenic staphylococci as vaccine delivery vehicles. In: Recombinant Gram-positive Bacteria as Vaccine Vehicles for Mucosal Immunization (Wells, J. and Pozzi, G., Eds.), pp. 61-81. R.G. Landes, Springer-Verlag, New York.
10. Andréoni C., Goetsch L., Libon C., Samuelson P., Robert A., Nguyen T.N., Uhlén M., Binz H., Ståhl S. Flow cytometric quantification of surface-displayed recombinant receptors on staphylococci. BioTechniques. 23:1997;696-704.
11. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:1992;75-88.
12. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 11:1993;1179-1184.
13. Nashar T.O., Amin T., Marcello A., Hirst T.R. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine. 11:1993;235-240.
14. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A.-M. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am. J. Trop. Med. Hyg. 50:1994;42-54.
15. Hirabayashi Y., Kurata H., Funato H., Nagamine T., Aizawa C., Tamura S.-I., Shimada K., Kurata T. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine. 8:1990;243-248.
16. Lehner T., Tao L., Panagiotidi C., Klavinskis L.S., Brookes R., Hussain L., Meyers N., Adams S.E., Gearing A.J.H., Bergmeier L.A. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 68:1994;1624-1632.
17. Oien N.L., Brideau R.J., Walsh E.E., Wathen M.W. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine. 12:1994;731-735.
18. Dertzbaugh M.T., Elson C.O. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect. Immun. 61:1993;384-390.
19. Staats H.F., Jackson R.J., Marinaro M., Takahashi I., Kiyono H., McGhee J.R. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immunol. 6:1994;572-583.
20. Delmas A., Partidos C.D. The binding of chimeric peptides to GM1 ganglioside enables induction of antibody responses after intranasal immunization. Vaccine. 14:1996;1077-1082.
21. Ståhl S., Hansson M., Ahlborg N., Nguyen T.N., Liljeqvist S., Lundeberg J., Uhlén M. Solid-phase gene assembly of constructs derived from the Plasmodium falciparum malaria blood-stage antigen Ag332. BioTechniques. 14:1993;424-434.
22. Nguyen, T.N., Uhlén, M. and Ståhl, S. (1994) De novo gene assembly using a paramagnetic solid support. In: Advances in Biomagnetic Separation (Uhlén, M., Hornes, E. and Olsvik, Ø., Eds.), pp. 73-78. Eaton, Natick, MA.
23. Hultman T., Ståhl S., Moks T., Uhlén M. Approaches to solid phase DNA sequencing. Nucleosides Nucleotides. 7:1988;629-638.
24. Götz F., Schumacher B. Improvements of protoplast transformation in Staphylococcus carnosus. FEMS Microbiol. Lett. 40:1987;285-288.
25. Götz, F. (1990) Staphylococcus carnosus: a new host organism for gene cloning and protein production. J. Appl. Bacteriol. Symp. Suppl., 49S-53S.
26. Liebl W., Götz F. Studies on lipase directed exprot of Escherichia coli β-lactamase in Staphylococcus carnosus. Mol. Gen. Genet. 204:1986;166-173.
27. Schneewind O., Fowler A., Faull K.F. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Nature. 268:1995;103-106.
28. Ton-That H., Faull K.F., Schneewind O. Anchor structure of staphylococcal surface proteins. A branched peptide that links the carboxyl terminus of proteins to the cell wall. J. Biol. Chem. 272:1997;22285-22292.
29. Nygren P.-Å., Eliasson M., Palmcrantz E., Abrahmsén L., Uhlén M. Analysis and use of the serum albumin binding domains of streptococcal protein G. J. Mol. Recognit. 1:1988;69-74.
30. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
31. Ayora S., Lindgren P.-E., Götz F. Biochemical properties of a novel metalloprotease from Staphylococcus hyicus subsp. hyicus involved in extracellular lipase processing. J. Bacteriol. 176:1994;3218-3223.
32. Demleitner G., Götz F. Evidence for importance of the Staphylococcus hyicus lipase pro-peptide in lipase secretion, stability and activity. FEMS Microbiol. Lett. 121:1994;189-198.